Enovis (ENOV) Receivables - Other (2010 - 2020)

Enovis (ENOV) posted quarterly Receivables - Other of $34.7 million for Q4 2020, up 675.01% quarter-over-quarter from $4.5 million in Q3 2020.

Enovis (ENOV) Receivables - Other (2010 - 2020) Analysis & Trends

Enovis (ENOV) has reported Receivables - Other for 11 consecutive years, with $34.7 million the latest figure, recorded in Q4 2020.

In Q4 2020, Receivables - Other changed N/A year-over-year to $34.7 million; the TTM figure through Oct 2020 stood at $34.7 million (changed N/A YoY), while the FY2019 annual figure was $4.5 million, down 97.34% from the prior year.
Receivables - Other advanced to $34.7 million in Q4 2020 per ENOV's latest filing, from $4.5 million in the prior quarter.
Across five years, Receivables - Other topped out at $203.9 million in Q4 2017 and bottomed at $4.5 million in Q4 2019.
Historically, Receivables - Other has averaged $113.5 million across 5 years, with a median of $159.5 million in 2018.
Annual changes were most pronounced in 2016 — Receivables - Other increased 16.99% — and 2019, when it plunged 97.34%.
Enovis' Receivables - Other stood at $174.9 million in 2016, then grew by 16.58% to $203.9 million in 2017, then fell by 17.46% to $168.3 million in 2018, then slumped by 97.34% to $4.5 million in 2019, then soared by 675.01% to $34.7 million in 2020.
Business Quant data shows ENOV's Receivables - Other at $34.7 million in Q4 2020, $4.5 million in Q3 2020, and $4.5 million in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	200.51 Bn	194.91 Bn	7.27 Bn
2	Stryker	129.96 Bn	126.48 Bn	4.50 Bn
3	Medtronic	120.18 Bn	110.96 Bn	6.41 Bn
4	Boston Scientific	74.28 Bn	73.74 Bn	3.85 Bn
5	Edwards Lifesciences	52.75 Bn	48.50 Bn	1.35 Bn
6	Dexcom	34.67 Bn	32.73 Bn	830.00 Mn
7	GE HealthCare Technologies	34.23 Bn	32.12 Bn	2.18 Bn
8	Koninklijke Philips	26.46 Bn	23.14 Bn	4.55 Bn
9	Steris	23.30 Bn	22.82 Bn	684.20 Mn
10	Enovis	1.53 Bn	1.52 Bn	359.25 Mn

Download Data